Application of serum PSA to identify acute bacterial prostatitis in patients with fever of unknown origin or symptoms of acute pyelonephritis

Prostate

Volumn 60, Issue 4, 2004, Pages 282-288

  Hara, Noboru ^a,b   Koike, Hiroshi ^a   Ogino, Sojiro ^a   Okuizumi, Mina ^a   Kawaguchi, Mokoto ^a  

^a Niigata Rousai Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Acute bacterial prostatitis; Misdiagnosis; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACUTE PYELONEPHRITIS; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEVER; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATITIS; PYREXIA IDIOPATHICA; RANDOMIZATION; UROGENITAL TRACT INFECTION;

ACUTE DISEASE; ADULT; AGED; BACTERIAL INFECTIONS; DIAGNOSTIC ERRORS; FEVER OF UNKNOWN ORIGIN; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATITIS; PYELONEPHRITIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 3943050712     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20077     Document Type: Article

References (34)

1. Petersdorf RG, Beeson PB. Fever of unknown origin-report on 100 cases. Medicine 1961;40:1.
2. Durack DT, Street AC. Fever of unknown origin-Reexamined and redefined. Curr Clin Top Infect Dis 1991;11:35-51.
3. Mourad O, Palda V, Detsky AS. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003;163:545-551.
4. Amin K, Kauffman CA. Fever of unknown origin. A strategic approach to this diagnostic dilemma. Postgrad Med 2003;114: 69-75.
5. 18F] fluorodeoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001;32:191-196.
6. Kodama Y, Arisaka Y, Higashi K, Taki S, Taniguchi M, Oguchi M, Tonami H, Yamamoto I, Hori A, Kurose N. Polymyositis detected by Ga-67 scintigraphy. Clin Nucl Med 2002;27:837-839.
7. Arch-Ferrer JE, Velazquez-Fernandez D, Sierra-Madero J, Lopez-Karpovitch X, Angeles-Angeles A, Gamino R, Herrera MF. Laparoscopic approach to fever of unknown origin. Surg Endosc 2003;17:494-497.
8. Samm BJ, Dmochowski RR. Urologic emergencies. Conditions affecting the kidney, ureter, bladder, prostate, and urethra. Postgrad Med 1996;100:177-180, 183-184.
9. Nickel JC. Classification and diagnosis of prostatitis: A gold standard? Andrologia 2003;35:160-167.
10. Yaman O, Gogus C, Tulunay O, Tokatli Z, Ozden E. Increased prostate-specific antigen in subclinical prostatitis: The role of aggressiveness and extension of inflammation. Urol Int 2003;71: 160-164.
11. Horcajada JP, Vilana R, Moreno-Martinez A, Alvarez-Vijande R, Bru C, Bargallo X, Bunesch L, Martinez JA, Mensa J. Transrectal prostatic ultrasonography in acute bacterial prostatitis: Findings and clinical implications. Scand J Infect Dis 2003; 35:114-120.
12. Procopiou M, Genne D, Abbet P, Defabiani N, Rohner S, Auckenthaler R. Acute prostatitis with prostatic abscess caused by group B streptococcus. Clin Infect Dis 1998;27:403-404.
13. Soda T, Ogura K, Ishitoya S, Niibayashi H, Yoshida O. Pyogenic vertebral osteomyelitis after acute bacterial prostatitis: A case report. Int J Urol 1996;3:402-405.
14. el-Shirbiny AM. Prostatic specific antigen. Adv Clin Chem 1994; 31:99-133.
15. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994;151: 1283-1290.
16. Neal DE Jr., Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992;20: 105-111.
17. Pansadoro V, Emiliozzi P, Defidio L, Scarpone P, Sabatini G, Brisciani A, Lauretti S. Prostate-specific antigen and prostatitis in men under fifty. Eur Urol 1996;30:24-27.
18. Ornstein DK, Smith DS, Humphrey PA, Catalona WJ. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 1998;159:1234-1237.
19. Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y. RT-PCR detection of prostate specific antigen, prostate specific membrane antigen and prostate stem cell antigen in one milliliter of peripheral blood: Value for the staging of prostate cancer. Clin Cancer Res 2002;8:1794-1799.
20. Blijenberg BG, Storm BN, Kruger AE, Schroder FH. On the standardization of total prostate-specific antigen: An exercise with two reference preparations. Clin Chem Lab Med 1999;37: 545-552.
21. Kano S, Ishibashi M, Itoh Y. PSA ad hoc Committee of Japanese Urological Association. The present status of standardization in serum total PSA measurement-A result of "Survey 2000" conducted by PSA ad hoc Committee of Japanese Urological Association. Rinsho Byori 2001;49:967-973.
22. Bo M, Ventura M, Marinello R, Capello S, Casetta G, Fabris F. Relationship between prostatic specific antigen (PSA) and volume of the prostate in the benign prostatic hyperplasia in the elderly. Crit Rev Oncol Hematol 2003;47:207-211.
23. Preston DM, Levin LI, Jacobson DJ, Jacobsen SJ, Rubertone M, Holmes E, Murphy GP, Moul JW. Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology 2000;56:812-816.
24. Cox CE, Holloway WJ, Geckler RW. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Clin Infect Dis 1995;21:86-92.
25. Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol 2001;42:348-354.
26. Moon TD, Clejan S, Neal DE Jr. Prostate specific antigen and prostatitis. II. PSA production and release kinetics in vitro. Prostate 1992;20:113-116.
27. Hochreiter WW. Male accessory gland infection: Standardization of inflammatory parameters including cytokines. Andrologia 2003;35:300-303.
28. Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, O'Brien AD. Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun 2001; 69:6515-6519.
29. Zackrisson B, Ulleryd P, Aus G, Lilja H, Sandberg T, Hugosson J. Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infection. Urology 2003;62:278-281.
30. Zhang WM, Leinonen J, Kalkkinen N, Stenman UH. Prostate-specific antigen forms a complex with and cleaves alpha 1-protease inhibitor in vitro. Prostate 1997;33:87-96.
31. Recker F, Kwiatkowski MK, Pettersson K, Piironen T, Lummen G, Huber A, Tscholl R. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia. Eur Urol 1998; 33:549-555,
32. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002;287:2701-2710.
33. Horcajada JP, Vilana R, Moreno-Martinez A, Alvarez-Vijande R, Bru C, Bargallo X, Bunesch L, Martinez JA, Mensa J. Transrectal prostatic ultrasonography in acute bacterial prostatitis: Findings and clinical implications. Scand J Infect Dis 2003;35:114-120.
34. 111Indium labeled leukocyte scintigraphy in the detection of acute prostatitis. Nucl Med Commun 2002;23:1137-1142.